Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Chung Shan Medical University
  3. Pure學術人才庫轉入
  4. Coral Hydrate improves renal fibrosis by inhibiting indoxyl sulfate-induced ROS-mediated NLRP3 inflammasome activation
 
  • Details
Options

Coral Hydrate improves renal fibrosis by inhibiting indoxyl sulfate-induced ROS-mediated NLRP3 inflammasome activation

Journal
European Journal of Pharmacology
Date Issued
2025-12-05
Author(s)
YI-HSIEN HSIEH  
TUNG-WEI HUNG  
HUI-LING CHIOU  
SHAO-HSUAN KAO  
DOI
10.1016/j.ejphar.2025.178367
URI
https://www.scopus.com/pages/publications/105021873025
https://scholars.csmu.edu.tw/handle/123456789/24220
Abstract
Chronic kidney disease (CKD) is a global kidney disease characterized by chronic inflammation, oxidative stress and fibrosis in the kidney. A hydrogenated coral material known as coral hydrate (CH) has potent antioxidant activity. However, the effect of CH on renal fibrosis is rarely explored. This study aims to determine the effects of CH on renal fibrosis and indoxyl sulfate (IS)-induced renal cell injury and to elucidate the mechanisms underlying such effects. In vivo unilateral ureteral obstruction (UUO) mouse model, our findings showed that UL-CH group (UUO mice administered with low-dose CH) or UH-CH group (UUO mice administered with high-dose CH) significantly ameliorated renal fibrosis, reduced the levels of collagen I, α-smooth muscle actin (α-SMA), vimentin, Snail and Slug in renal tissues in addition to decreasing the levels of NLRP3, cleaved (c)-caspase-1, and c-IL-1β. In NRK-52E cells, CH downregulated IS-induced NLRP3, c-caspase-1, and c-IL-1β. CH treatment resulted in decreased ROS, HO-1, and p-NRF2 induced by IS stimulation, and combination treatment with CH and the NLRP3 inhibitor MCC950 further reduced NLRP3 inflammasome to levels lower than those with CH treatment alone. Collectively, these results indicate that CH has the potential to ameliorate NLRP3 inflammasome-mediated renal fibrosis.
Type
journal article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback